A Review of molecular and genetic diagnostics of myeloid malignancies with emphasis on diagnostics in Bosnia and Herzegovina

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F21%3AE0109323" target="_blank" >RIV/00843989:_____/21:E0109323 - isvavai.cz</a>

Výsledek na webu

<a href="http://www.ama.ba/index.php/ama/article/view/453/pdf" target="_blank" >http://www.ama.ba/index.php/ama/article/view/453/pdf</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.5644/ama2006-124.334" target="_blank" >10.5644/ama2006-124.334</a>

Jazyk výsledku

angličtina

Název v původním jazyce

A Review of molecular and genetic diagnostics of myeloid malignancies with emphasis on diagnostics in Bosnia and Herzegovina

Popis výsledku v původním jazyce

Here we describe the major genetic and genomic aberrations found in myeloid malignancies and how those markers are used in patients' diagnosis, prognosis, and targeted treatment. In Bosnia and Herzegovina, cytogenetic and molecular diagnostics for myeloid malignancies have been established and continually improved since 2005. We report the current state of available diagnostic tools for myeloid malignancies in Bosnia and Herzegovina. Myeloid malignancies are a heterogeneous group of clonal blood diseases characterized by defects in hematopoietic stem cells and myeloid progenitors that lead to abnormal proliferation, differentiation, localization, and self-renewal. Most common myeloid malignancies include myeloproliferative neoplasms (MPNs), myelodysplastic syndrome (MDS), and acute myeloid leukemia (AML). Molecular diagnostics of myeloid malignancies have significantly expanded in the last decade with new genetic and genomic markers for diagnosis, prognosis, and treatment. CONCLUSION: In the last decade, several new genomic markers important for patient diagnosis, prognosis, and therapy have been discovered that need to be implemented in routine molecular diagnostics not only in developed nations but also in developing nations such as Bosnia and Herzegovina.

Název v anglickém jazyce

A Review of molecular and genetic diagnostics of myeloid malignancies with emphasis on diagnostics in Bosnia and Herzegovina

Popis výsledku anglicky

Here we describe the major genetic and genomic aberrations found in myeloid malignancies and how those markers are used in patients' diagnosis, prognosis, and targeted treatment. In Bosnia and Herzegovina, cytogenetic and molecular diagnostics for myeloid malignancies have been established and continually improved since 2005. We report the current state of available diagnostic tools for myeloid malignancies in Bosnia and Herzegovina. Myeloid malignancies are a heterogeneous group of clonal blood diseases characterized by defects in hematopoietic stem cells and myeloid progenitors that lead to abnormal proliferation, differentiation, localization, and self-renewal. Most common myeloid malignancies include myeloproliferative neoplasms (MPNs), myelodysplastic syndrome (MDS), and acute myeloid leukemia (AML). Molecular diagnostics of myeloid malignancies have significantly expanded in the last decade with new genetic and genomic markers for diagnosis, prognosis, and treatment. CONCLUSION: In the last decade, several new genomic markers important for patient diagnosis, prognosis, and therapy have been discovered that need to be implemented in routine molecular diagnostics not only in developed nations but also in developing nations such as Bosnia and Herzegovina.

Druh

J_SC - Článek v periodiku v databázi SCOPUS

CEP obor

—

OECD FORD obor

30205 - Hematology

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2021

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Acta medica academica

ISSN

1840-1848

e-ISSN

1840-2879

Svazek periodika

50

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

BA - Bosna a Hercegovina

Počet stran výsledku

22

Strana od-do

175-196

Kód UT WoS článku

—

EID výsledku v databázi Scopus

2-s2.0-85107424236